National Comprehensive Cancer Network



About NCCN

Pancreatic Adenocarcinoma Panel: Imaging Sub-Committee - Disclosures as of 4/19/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Mahmoud Al-Hawary, MD

None

None

None

None

None

12/13/2013

Elliot K. Fishman, MD

General Electric;
Siemens Medical Solutions Diagnostics

None

None

None

None

6/20/2014

Isaac R Francis, MD

None

None

None

None

None

12/7/2014

Dushyant V. Sahani, MD

None

None

None

None

None

12/4/2014

Eric Tamm, MD

None

None

None

None

None

1/21/2015

Margaret A. Tempero, MD

Bayer HealthCare

Celgene Corporation;
Myriad Genetic Laboratories, Inc.

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Covidien AG;
Genentech, Inc.;
Myriad Genetic Laboratories, Inc.;
Asuragen;
Bionomics;
NuCana BioMed;
Peregrine;
Quest Diagnostic

None

None

2/24/2014